Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,924 | 88 | 95.7% |
| Education | $85.78 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $396.27 | 13 | $0 (2024) |
| Lilly USA, LLC | $222.60 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $169.02 | 8 | $0 (2024) |
| Novo Nordisk Inc | $163.60 | 9 | $0 (2024) |
| Smith+Nephew, Inc. | $161.53 | 4 | $0 (2024) |
| Abbott Laboratories | $130.02 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $111.43 | 2 | $0 (2024) |
| Amgen Inc. | $105.49 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $87.61 | 5 | $0 (2024) |
| Exact Sciences Corporation | $61.68 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $813.19 | 35 | AstraZeneca Pharmaceuticals LP ($137.73) |
| 2023 | $426.44 | 21 | Organogenesis Inc. ($189.41) |
| 2022 | $262.52 | 15 | Novo Nordisk Inc ($53.02) |
| 2021 | $237.34 | 9 | ORGANOGENESIS INC. ($143.57) |
| 2020 | $145.47 | 8 | Lilly USA, LLC ($62.21) |
| 2019 | $85.00 | 1 | Smith+Nephew, Inc. ($85.00) |
| 2018 | $40.00 | 1 | Ethicon US, LLC ($40.00) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 02/22/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $124.40 | General |
| Category: Wound Care | ||||||
| 01/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diabetes | ||||||
| 01/27/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $18.79 | General |
| Category: Wound Care | ||||||
| 01/18/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: Wound Care | ||||||
| 12/19/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes Care | ||||||
| 11/29/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: UROLOGY | ||||||
| 11/17/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
| 10/31/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Education | In-kind items and services | $0.79 | General |
| Category: UROLOGY | ||||||
| 10/11/2022 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Hematology | ||||||
| 09/13/2022 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Pharma Products | ||||||
| 08/29/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Diabetes | ||||||
| 08/24/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/19/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.64 | General |
| 07/07/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $17.54 | General |
| Category: Cardiovascular | ||||||
| 05/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Diabetes Care | ||||||
| 03/25/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 02/09/2022 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| 02/08/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 12/14/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Diabetes Care | ||||||
| 09/14/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Diabetes Care | ||||||
| 08/25/2021 | Hydrofera LLC | HYDROFERA BLUE READY - BORDER (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: WOUND CARE | ||||||
| 08/03/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $26.74 | General |
| Category: Wound Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,708 | 2,695 | $488,276 | $187,911 |
| 2022 | 22 | 1,518 | 2,932 | $557,284 | $191,602 |
| 2021 | 27 | 1,442 | 2,841 | $523,916 | $170,411 |
| 2020 | 23 | 1,043 | 1,755 | $490,318 | $106,835 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 279 | 1,045 | $262,295 | $93,270 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 227 | 227 | $58,112 | $28,541 | 49.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 54 | 76 | $41,268 | $15,290 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 191 | $34,189 | $12,280 | 35.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 115 | 116 | $19,372 | $8,852 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 50 | $17,800 | $6,506 | 36.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 255 | 255 | $9,435 | $4,461 | 47.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 236 | 236 | $8,496 | $4,142 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $9,930 | $2,873 | 28.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 17 | $6,851 | $2,469 | 36.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 82 | 82 | $4,346 | $2,075 | 47.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,619 | $1,692 | 46.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 26 | $2,886 | $1,125 | 39.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $1,085 | $937.44 | 86.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 59 | 84 | $2,352 | $817.49 | 34.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 17 | $1,768 | $685.44 | 38.8% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 31 | 31 | $1,240 | $633.87 | 51.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 14 | 16 | $1,520 | $600.32 | 39.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 32 | $928.00 | $360.96 | 38.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 13 | $429.00 | $210.60 | 49.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 109 | $355.00 | $91.63 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 1,002 | $251,502 | $88,982 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 186 | 186 | $47,616 | $23,632 | 49.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 51 | 75 | $40,725 | $15,976 | 39.2% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 64 | 337 | $85,935 | $15,854 | 18.4% |
About Dr. Aasma Riaz, MD
Dr. Aasma Riaz, MD is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1497981187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aasma Riaz, MD has received a total of $2,010 in payments from pharmaceutical and medical device companies, with $813.19 received in 2024. These payments were reported across 90 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,924).
As a Medicare-enrolled provider, Riaz has provided services to 5,711 Medicare beneficiaries, totaling 10,223 services with total Medicare billing of $656,760. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Clermont, FL
- Active Since 06/08/2009
- Last Updated 10/04/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497981187
Products in Payments
- Puraply (Medical Supply) $279.49
- MOUNJARO (Drug) $111.34
- Otezla (Drug) $105.49
- AIRSUPRA (Drug) $93.62
- TRELEGY ELLIPTA (Drug) $87.61
- Ozempic (Drug) $87.51
- PICO 7 Single Use Negative Pressure Wound Therapy (Device) $85.00
- EMGALITY (Drug) $77.90
- Cologuard Collection Kit (Device) $61.68
- INNOVAMATRIX AC (Device) $61.58
- Rybelsus (Drug) $61.45
- Puraply Antimicrobial (Medical Supply) $53.49
- HYDROFERA BLUE READY - BORDER (Device) $53.07
- FARXIGA (Drug) $52.27
- FREESTYLE LIBRE 3 (Device) $47.22
- LINX Reflux Management System (Device) $40.00
- FREESTYLE LIBRE 2 (Device) $35.40
- TRULICITY (Drug) $33.36
- Livalo (Drug) $33.24
- ACCRUFER (Drug) $32.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clermont
Sumith Aleti, Md, MD
Internal Medicine — Payments: $29,143
Alexander Bolanos, M.d, M.D
Internal Medicine — Payments: $15,769
Nathan Bibliowicz, Do, DO
Internal Medicine — Payments: $14,320
Dr. Shazia Nasir, Md, MD
Internal Medicine — Payments: $11,207
Carolina Mejia Otero, M.d, M.D
Internal Medicine — Payments: $7,926
Dr. Kiran Mogali, M.d, M.D
Internal Medicine — Payments: $7,620